We are live on ! Find out more
KFC

Klingenstein Fields & Co Portfolio holdings

AUM $2.54B
1-Year Est. Return 22.19%
This Fund
S&P 500
This Quarter Est. Return
+3%
1 Year Est. Return
+22.19%
3 Year Est. Return
+76.82%
5 Year Est. Return
+87.33%
10 Year Est. Return
+300.59%
AUM
$2.48B
AUM Growth
-$34.4M
Cap. Flow
-$68.7M
Cap. Flow %
-2.77%
Top 10 Hldgs %
37.3%
Holding
187
New
3
Increased
37
Reduced
75
Closed
7

Top Buys

Rank Stock Value
1
REGN icon
Regeneron Pharmaceuticals
REGN
+$5.23M
2
LLY icon
Eli Lilly
LLY
+$431K
3
ABT icon
Abbott
ABT
+$312K
4
EXEL icon
Exelixis
EXEL
+$227K
5
VOO icon
Vanguard S&P 500 ETF
VOO
+$226K

Top Sells

Rank Stock Value
1
SCHF icon
Schwab International Equity ETF
SCHF
+$15.5M
2
SCHE icon
Schwab Emerging Markets Equity ETF
SCHE
+$14M
3
XLK icon
State Street Technology Select Sector SPDR ETF
XLK
+$11.5M
4
AVGO icon
Broadcom
AVGO
+$8.48M
5
SCHA icon
Schwab U.S Small- Cap ETF
SCHA
+$3.08M

Sector Composition

Rank Sector Weight
1 Technology 26.97%
2 Financials 13.87%
3 Healthcare 11.95%
4 Communication Services 10.39%
5 Industrials 8.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VRTX icon
126
Vertex Pharmaceuticals
VRTX
$123B
$403K 0.02%
1,000
– –
V icon
127
Visa
V
$682B
$393K 0.02%
1,245
-80
-6% -$24.1K
CBT icon
128
Cabot Corp
CBT
$4.67B
$393K 0.02%
4,300
– –
IWO icon
129
iShares Russell 2000 Growth ETF
IWO
$14.7B
$384K 0.02%
1,335
– –
VWO icon
130
Vanguard FTSE Emerging Markets ETF
VWO
$119B
$374K 0.02%
8,498
– –
CRM icon
131
Salesforce
CRM
$140B
$365K 0.01%
1,091
-18
-2% -$5.75K
WFC icon
132
Wells Fargo
WFC
$265B
$359K 0.01%
5,108
+278
+6% +$19K
PFE icon
133
Pfizer
PFE
$143B
$358K 0.01%
13,509
-3,753
-22% -$102K
VEA icon
134
Vanguard FTSE Developed Markets ETF
VEA
$226B
$351K 0.01%
7,330
– –
QCOM icon
135
Qualcomm
QCOM
$181B
$349K 0.01%
2,275
– –
CWI icon
136
State Street SPDR MSCI ACWI ex-US ETF
CWI
$2.72B
$349K 0.01%
12,496
+130
+1% +$3.8K
WLY icon
137
John Wiley & Sons Class A
WLY
$2.59B
$346K 0.01%
7,909
– –
EAGL
138
Eagle Capital Select Equity ETF
EAGL
$4.4B
$345K 0.01%
12,399
-10,592
-46% -$298K
USRT icon
139
iShares Core US REIT ETF
USRT
$4.63B
$336K 0.01%
5,867
– –
WMT icon
140
Walmart Inc
WMT
$909B
$324K 0.01%
3,584
– –
IVW icon
141
iShares S&P 500 Growth ETF
IVW
$73.1B
$317K 0.01%
3,120
– –
BLK icon
142
Blackrock
BLK
$166B
$315K 0.01%
307
+3
+1% +$3.04K
AMGN icon
143
Amgen
AMGN
$198B
$313K 0.01%
1,199
– –
EG icon
144
Everest Group
EG
$15.1B
$308K 0.01%
850
– –
AVAV icon
145
AeroVironment
AVAV
$7.2B
$308K 0.01%
2,000
– –
GM icon
146
General Motors
GM
$68.6B
$307K 0.01%
5,758
– –
FNF icon
147
Fidelity National Financial
FNF
$14B
$307K 0.01%
5,461
– –
DOW icon
148
Dow Inc
DOW
$21.6B
$306K 0.01%
7,624
-190
-2% -$8.87K
QUAL icon
149
iShares MSCI USA Quality Factor ETF
QUAL
$46.1B
$295K 0.01%
1,658
– –
MRSH
150
Marsh
MRSH
$87.8B
$291K 0.01%
1,370
– –
4 5
6
7 8

Similar funds

OBAM
ODDO BHF Asset Management Paris, France $2.54B AUM 41.83% 1-Year Est. Return
LIMS
Lasalle Investment Management Securities Baltimore, Maryland $2.53B AUM 2.06% 1-Year Est. Return
LC
L1 Capital Melbourne VIC 3000, Australia $2.55B AUM 80.12% 1-Year Est. Return
DJSG
D.J. St. Germain Springfield, Massachusetts $2.53B AUM 17.43% 1-Year Est. Return
SAM
Securian Asset Management St Paul, Minnesota $2.53B AUM 25.83% 1-Year Est. Return
JHP
James Hambro & Partners London, United Kingdom $2.55B AUM 17.58% 1-Year Est. Return
YDMI
Y.D. More Investments Ramat Gan, Israel $2.55B AUM 104.35% 1-Year Est. Return
ECP
Electron Capital Partners New York $2.55B AUM 87.77% 1-Year Est. Return

Klingenstein Fields & Co's Q4 2024 Portfolio in Review

As of Q4 2024, Klingenstein Fields & Co held 187 positions worth $2.48B, down 1.4% from $2.52B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Klingenstein Fields & Co's Q4 2024 filing shows 3 new, 37 increased, 75 reduced and 7 closed positions. Its largest new stake was Exelixis: 7,000 shares worth $233K. The largest sale was Schwab International Equity ETF, an estimated $15.5M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 25% a quarter earlier, followed by Financials and Healthcare.

  • Klingenstein Fields & Co's largest Q4 2024 buy was Exelixis: 7,000 shares worth $233K.
  • Klingenstein Fields & Co added most to Regeneron Pharmaceuticals in Q4 2024, an estimated $5.23M increase.
  • Klingenstein Fields & Co's biggest Q4 2024 reduction was Schwab International Equity ETF, cutting an estimated $15.5M.
  • Klingenstein Fields & Co fully exited First Trust Long/Short Equity ETF in Q4 2024, selling an estimated $2.04M.
  • Klingenstein Fields & Co's ten largest holdings make up 37% of its $2.48B portfolio in Q4 2024.
  • Klingenstein Fields & Co opened 3 new positions and closed 7 in Q4 2024.
  • Klingenstein Fields & Co's portfolio value fell 1.4% quarter-over-quarter to $2.48B.

Based on Klingenstein Fields & Co's 13F filing for Q4 2024, filed 30 Jan 2025.